MHRP has launched its first study in the Eastern European country of Georgia to characterize HIV risks, molecular epidemiology and related infections. As part of the study, MHRP is working closely with WRAIR’s forward directorate in Tblisi, WRAIR-Europe-Middle East, and the Tengiz Tsertsvadze Infectious Diseases, AIDS and Clinical Immunology Research Center.
WRAIR Europe-Middle East was established in Tbilisi in 2014 and works closely with regional partners to surveil infectious disease threats like acute febrile illness, respiratory infection and antimicrobial resistance. This will be the site’s first HIV study.